Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations
H Jadvar - European journal of nuclear medicine and molecular …, 2013 - Springer
Prostate cancer is a major public health problem in developed countries. The remarkable
biological and clinical heterogeneity of prostate cancer provides unique opportunities as …
biological and clinical heterogeneity of prostate cancer provides unique opportunities as …
Molecular imaging of prostate cancer
Prostate cancer is the most common noncutaneous malignancy among men in the Western
world. The natural history and clinical course of prostate cancer are markedly diverse …
world. The natural history and clinical course of prostate cancer are markedly diverse …
Molecular imaging of prostate cancer: PET radiotracers
H Jadvar - American Journal of Roentgenology, 2012 - Am Roentgen Ray Soc
OBJECTIVE. Recent advances in the fundamental understanding of the complex biology of
prostate cancer have provided an increasing number of potential targets for imaging and …
prostate cancer have provided an increasing number of potential targets for imaging and …
[HTML][HTML] Preclinical applications of 3'-deoxy-3'-[18F] Fluorothymidine in oncology-a systematic review
S Schelhaas, K Heinzmann, VR Bollineni… - Theranostics, 2017 - ncbi.nlm.nih.gov
The positron emission tomography (PET) tracer 3'-deoxy-3'-[18 F] fluorothymidine ([18 F]
FLT) has been proposed to measure cell proliferation non-invasively in vivo. Hence, it …
FLT) has been proposed to measure cell proliferation non-invasively in vivo. Hence, it …
Preclinical imaging of prostate cancer
C Olkowski, B Fernandes, GL Griffiths, F Lin… - Seminars in Nuclear …, 2023 - Elsevier
Prostate cancer remains a major cause of mortality and morbidity, affecting millions of men,
with a large percentage expected to develop the disease as they reach advanced ages …
with a large percentage expected to develop the disease as they reach advanced ages …
Update on positron emission tomography for imaging of prostate cancer
K Kitajima, RC Murphy, MA Nathan… - International Journal of …, 2014 - Wiley Online Library
Prostate cancer is the most common non‐cutaneous malignancy among men in the W
estern world, and continues to be a major health problem. Imaging has recently become …
estern world, and continues to be a major health problem. Imaging has recently become …
Pharmacokinetics and PET imaging properties of two recombinant anti‐PSMA antibody fragments in comparison to their parental antibody
S Wiehr, P Bühler, D Gierschner, P Wolf… - The …, 2014 - Wiley Online Library
BACKGROUND Radioimmunoimaging with disease‐specific tracers can be advantageous
compared to that with nonspecific tracers for the imaging of glucose metabolism and cell …
compared to that with nonspecific tracers for the imaging of glucose metabolism and cell …
[HTML][HTML] 18F-FDG-PET/CT and 18F-NaF-PET/CT in men with castrate-resistant prostate cancer
KA Zukotynski, CK Kim, VH Gerbaudo… - American journal of …, 2015 - ncbi.nlm.nih.gov
To evaluate 18 F-labeled-fluorodeoxyglucose (18 F-FDG-) and 18 F-labeled-sodium fluoride
(18 F-NaF-) positron emission tomography/computed tomography (PET/CT) as biomarkers …
(18 F-NaF-) positron emission tomography/computed tomography (PET/CT) as biomarkers …
A comparative study of peptide-based imaging agents [68Ga] Ga-PSMA-11,[68Ga] Ga-AMBA,[68Ga] Ga-NODAGA-RGD and [68Ga] Ga-DOTA-NT-20.3 in preclinical …
J Zhang-Yin, C Provost, G Cancel-Tassin… - Nuclear Medicine and …, 2020 - Elsevier
Introduction Peptide-based imaging agents targeting prostate-specific membrane antigen
(PSMA) have revolutionized the evaluation of biochemical recurrence of prostate cancer …
(PSMA) have revolutionized the evaluation of biochemical recurrence of prostate cancer …
[HTML][HTML] PET/CT in prostate cancer: non-choline radiopharmaceuticals
P Castellucci, H Jadvar - The quarterly journal of nuclear medicine …, 2012 - ncbi.nlm.nih.gov
In this brief review, the major potential clinical applications of 18 F-FDG, 11 C-acetate, 18 F-
FDHT, 18 F-FLT, 18 F-FMAU, and anti-18 F-FACBC in the imaging evaluation of men with …
FDHT, 18 F-FLT, 18 F-FMAU, and anti-18 F-FACBC in the imaging evaluation of men with …